Karuna Therapeu
Stock
Stock
ISIN: US48576A1007
Ticker: KRTX
US48576A1007
KRTX
Price
Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Karuna Therapeu?
Karuna Therapeu's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$11.73. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Karuna Therapeu's stock?
Currently, 1 analysts cover Karuna Therapeu's stock, with a consensus target price of $330.00. Analyst ratings provide insights into the stock's expected performance.
What is Karuna Therapeu's revenue over the trailing twelve months?
Over the trailing twelve months, Karuna Therapeu reported a revenue of $654.00K.
What is the EBITDA for Karuna Therapeu?
Karuna Therapeu's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$493.08M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Karuna Therapeu?
Karuna Therapeu has a free cash flow of -$388.74M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Karuna Therapeu have, and what sector and industry does it belong to?
Karuna Therapeu employs approximately 339 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
Financials
- EPS (TTM)
- -$11.73
- Revenue (TTM)
- $654.00K
- EBITDA (TTM)
- -$493.08M
- Free Cashflow (TTM)
- -$388.74M
Pricing
- 52W span
- $312.58$332.35
Analyst Ratings
The price target is $330.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
- Employees
- 339
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US48576A1007
- Primary Ticker
- KRTX